St. Mary’s Regional Medical Centers’ Center for Family Urology is one of a select number of medical centers nationwide offering a newly-approved optical imaging agent for the detection of bladder cancer. The availability of Blue Light Cystoscopy with Cysview signals the arrival of an innovative diagnostic technology for people who have or may have bladder cancer, and underscores St. Mary’s reputation as a leading comprehensive medical facility.
“This breakthrough technology not only helps me see and remove more cancerous tumors, it improves disease management,” said urologist Michael Parker, MD, St. Mary’s Center for Family Urology. “Because recurrent tumors are caught earlier, patients need less operative interventions.”
Bladder cancer is difficult to detect. A missed diagnosis can result in delayed or incomplete treatment, which may lead to serious complications and a lower chance of survival for patients with potentially aggressive tumors. Blue Light Cystoscopy with Cysview represents an important advance in diagnostic technology, enabling more accurate diagnosis of bladder tumors compared to the standard technique. Patients with known or suspected bladder cancer can now come to the Center for Family Urology to undergo diagnostic procedures administered by physicians who have been specially-trained in the use of this innovative technology. By facilitating early diagnosis of bladder cancer, this innovative imaging agent can enable appropriate, timely treatment that may improve patients’ chances of survival.
For more information about St. Mary’s Center for Family Urology or Blue Light Cystoscopy with Cysview, please visit www.stmarysmaine.com, to contact the office, please call 777-3150.